SMALES KELLY sold 4.8% of their position (4K shares) of TRANSPHORM, INC. on the open market
Open‑market sale worth $10.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/27/2023ACC: 0001209191-23-056731
-4K
Net shares
Net seller
$10.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4K
Price / share
$2.63
Trade value
$10.50K
% of position
4.8%
11/22/2023
83.63K→79.63K
Total
Net shares
−4K
Net value
-$10.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/22/2023 | S · Sale | −4K | $2.63 | $10.50K | 4.8% | 83.63K | 79.63K |
| Total | −4K | -$10.50K | ||||||
Derivative Transactions0
No derivative transactions reported